Want to see DE:RHK full AI Analyst Report?

RHON-KLINIKUM AG (RHK) Price & Analysis

0 Followers

RHK Stock Chart & Stats

€14.70

€0.20(1.57%)

At close: Jul 24 4:00 PM EDT

€14.70

€0.20(1.57%)

Day’s Range― - ―

52-Week Range€11.30 - €15.70

Previous CloseN/A

Volume551.00

Average Volume (3M)7.47K

Market Cap

€970.61M

Enterprise Value€889.42

Total Cash (Recent Filing)€556.55M

Total Debt (Recent Filing)€121.88M

Price to Earnings (P/E)22.7

Beta0.01

Next Earnings

Nov 05, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield1.38%

Share Statistics

EPS (TTM)0.64

Shares Outstanding66,962,470

10 Day Avg. Volume1,652

30 Day Avg. Volume7,472

Financial Highlights & Ratios

PEG Ratio-1.22

Price to Book (P/B)0.64

Price to Sales (P/S)0.44

P/FCF Ratio-24.57

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)0.64

Revenue Forecast (FY)€1.79B

Bulls Say, Bears Say

Bulls Say

Conservative Balance SheetLow leverage, declining debt, and a growing equity base provide RHÖN-KLINIKUM with a substantial financial cushion. This supports resilience across its hospital operations, reduces balance-sheet risk, and preserves flexibility to fund necessary investment or manage periods of weaker profitability.

Recent Revenue ExpansionThe strong 2025 revenue increase, following similarly robust growth in 2023, indicates the hospital and medical-services platform can expand its revenue base over time. Although the pattern is uneven, renewed growth improves operating scale and supports longer-term earnings recovery potential.

Proven Prior Cash GenerationRHÖN-KLINIKUM has demonstrated the ability to generate meaningful operating and free cash flow in prior years. That history provides evidence that the business can convert hospital activity into cash, supporting reinvestment and financial stability if recent weakness does not persist.

Bears Say

Sharp EBIT DeteriorationThe steep decline in EBIT while revenue increased signals substantial pressure on operating profitability. Persistent earnings weakness would reduce the return generated by the hospital platform, limit internally funded investment, and make future results more sensitive to cost developments.

Negative Latest Free Cash FlowA shift to negative free cash flow weakens near-term funding flexibility and means recent operating cash generation did not cover investment needs. If this pattern continues, RHÖN-KLINIKUM may have less capacity to fund expansion, maintain facilities, or absorb further earnings pressure internally.

Uneven, Thin ProfitabilityThin margins leave limited protection against operating volatility, while the 2024 revenue contraction demonstrates that growth is not yet consistent. This combination can make earnings less durable and leaves less room to absorb weaker activity before profitability or cash conversion deteriorates.

RHK FAQ

What was RHON-KLINIKUM AG’s price range in the past 12 months?

RHON-KLINIKUM AG lowest stock price was €11.30 and its highest was €15.70 in the past 12 months.

What is RHON-KLINIKUM AG’s market cap?

RHON-KLINIKUM AG’s market cap is €970.61M.

When is RHON-KLINIKUM AG’s upcoming earnings report date?

RHON-KLINIKUM AG’s upcoming earnings report date is Nov 05, 2026 which is in 51 days.

How were RHON-KLINIKUM AG’s earnings last quarter?

RHON-KLINIKUM AG released its earnings results on Aug 06, 2026. The company reported €0.135 earnings per share for the quarter.

Is RHON-KLINIKUM AG overvalued?

According to Wall Street analysts RHON-KLINIKUM AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does RHON-KLINIKUM AG pay dividends?

RHON-KLINIKUM AG pays a Annually dividend of €0.2 which represents an annual dividend yield of 1.38%. See more information on RHON-KLINIKUM AG dividends here

What is RHON-KLINIKUM AG’s EPS estimate?

RHON-KLINIKUM AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does RHON-KLINIKUM AG have?

RHON-KLINIKUM AG has 66,962,470 shares outstanding.

What happened to RHON-KLINIKUM AG’s price movement after its last earnings report?

RHON-KLINIKUM AG reported an EPS of €0.135 in its last earnings report. Following the earnings report the stock price went up 1.587%.

Which hedge fund is a major shareholder of RHON-KLINIKUM AG?

Currently, no hedge funds are holding shares in DE:RHK

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

RHON-KLINIKUM AG Stock Smart Score

Neutral

Technicals

Fundamentals

Return on Equity

1.38%

Trailing 12-Months

Asset Growth

-2.06%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

RHON-KLINIKUM AG

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, delivers extensive healthcare services across Germany, encompassing inpatient, day-patient, and outpatient treatment models. The company's hospitals provide a broad spectrum of medical and surgical care, including cardiovascular rehabilitation, specialized hand and trauma surgery, neurological and psychosomatic treatments, addiction therapy, ophthalmology, and dentistry. They also address conditions affecting the thoracic region, lungs, and vascular system, offer oncology services, and manage neurological conditions, spinal column and joint issues, as well as heart diseases. The organization operates eight hospitals, providing a total of 5,420 beds or patient slots across five distinct medical locations. RHÖN-KLINIKUM is headquartered in Bad Neustadt an der Saale, Germany.